Local Hospitals Respond To FDA Report - WLNS TV 6 Lansing - Jackson | Your Local News Leader

For the past two years, Lansing Ophthalmology received shipments from the Massachusetts Company NECC.

"As soon as we heard there were some issues with the New England Compounding Center, we took them off our shelves," said Executive Director Lansing Ophthalmology Charles Dobis.

Dobis says that medicine was an injection known as "Preserve Free Kenalog" used to reduce inflammation of the retina.

Kenalog is one of over 1200 products nationwide that has since been recalled by the NECC.

"We want them to know that the products we used have not been linked to the meningitis infections," Dobis said.

Sparrow Hospital started contacting people early Thursday morning once they learned they too had products from the center.

"We do have about 717 patients that have received a medication from the New England Compounding Center, that drug was on our shelves from July until early October," said Dr. Brian Schroeder.

Commonly known as Lasix, Dr. Brian Schroeder says that drug was used to reduce heart failure in patients.

"It's typically given either in the oral form or the iv form, only the I-v form is in question at this time."

Dr. Schroeder says Sparrow has notified those patients who may be affected.

"If they have not heard from us they have nothing to worry about, if they are not having any symptoms, they have nothing to worry about."

Dr. Schroeder says no one from Sparrow has had symptoms related to meningitis, but will continue to monitor affected patients.

@